The IC50 values of PPP are considerably low compared to that of other applied protein kinase inhibitors (Table 1), suggesting that PPP processes the highest potency inhibiting human lung cancer cell viability among three protein kinase inhibitors. This evidence concerns the gene WEE1 and lung cancer.